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   The finding of a relationship between bladder carcinoma and P－glucuronidase （B－G） in 1947
arose the atterition of many investigators． Thus a number of papers have reported the fact that a
P－G activity in urine is high among patients with bladder carcinoma． lt is， however， not．yet clear
what the main course of these observations is． The prgsent biochgmical studies were aimed to find
the relationship between the increase of P－G activity in urine of bladder carcin6ma patients and their
turnors． The data are summarized as follows：
1． The leygls gf P－G activity in both urine ancl seraln of blgdder carcinoma patients were higher
than those of the normal subjects． The P－G activity 6f the extract of bladder carcinoma was also
higher than that of the normal． The P－G’activity of the kidney extract was the highest value in the
normal subject， but ’there were no significant difference between the activity of kidney extract and
that of bladder carcinoma statistically．
2． By Pevicon block electrophoresis two bands from the bladder carcinoma extract and one band
from the normal b｝adder extract were observed．
3． By DEAE－cellulose column chrQmatography the P－G activity of the bladder carcinoma extragt
emerged as three peaks designated as Fractions 1， II and III， in contrast to one peak （Fr． 1） from
the normal biadder and two peaks （Fr． 1 4nd III）’from kidney・ were’detected． Fr． II was observed
only in the bladder carcinoma extract．
4． By DEAE－cellulose column chromatogr4phy the ’P－G actiyity of urine of bladder carcinoma pa－
tients was fractionated into three fractions （Fr． 1， II and III） in contr4＄t to two fractions （Fr． 1 and
III） of that of normal urine． Fr． II was also specific for urine of the bladder carcinoma patients，
likewise in’狽??tissue extract．
5． These’ dqta suggestc．． d that lhe P－G． 4ctivity in urine of the bladder carcinoma patient is apparently
derived from the carcinoma tissue．
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Fig． 1． P－glucuronidase activity of urlne．
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B－glucuronidase activity of tissu．es．
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Fig． 7．． DEAE－cellulose column chromatography of g， rinary P－glucuronidase in patients’
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はFr． 1はpH 4．6，に， Fr． IIおよびFr． IIIでは
pH 4．4にそれぞれ活性のピークを有するpH活性曲
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Fig． 11． Optimum pH of P－G on each fraction of
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Fig． 12． Optimum pH of B－G on each fraction
    of bladder carcinoma tissue．
線が得られた（Fig・11）．癌組織酵素では， Fr．1は























































































































Table 1． Frequency of peak in each fraction of various specimens．
          fraction
高≠狽?窒奄≠P
@  （case number）
  Fr正
獅浮高b??     （2）
  Fr互
獅浮高b??     （竃）
  Fr皿
獅浮高b??     （竃）
normal bladder
@・煤｡SSue











































































れ 膀胱癌患者尿では，Fr．1， II， IIIにβ一G活性が
認められた，
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